BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The offering is made pursuant to a shelf registration statement on Form S-3 declared effective by the SEC.
The net proceeds will be used to purchase gold bullion, for working capital, and general corporate purposes.
Offer Details
Shares of common stock to be offered through underwritten public offering.
Use of Proceeds
Net proceeds to be used for purchase of gold bullion, working capital, and corporate purposes.
Offer Management
Clear Street and Needham & Company are acting as joint book-running managers.
- BioSig's decision to offer shares indicates a strategic move to raise capital for specific purposes such as gold bullion purchase and working capital.
- The joint book-running managers suggest a strong support system for the success of the offering.
- The offering under the effective shelf registration statement enhances transparency and regulatory compliance.
The public offering by BioSig Technologies Inc. demonstrates a proactive approach to financing strategies, highlighting the company's commitment to its investment policy and operational growth.